1[1]Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and evalua ton. Am Heart J, 2002, 144 (5): 834-839.
2[2]Friedl W, Mair J, Thomas S, et al. Natriuretic peptides and cycligunano sinc 3' 5' monophosphate in asymptomatic left ventricular dysfunction. Heart, 1996, 76 (2): 129-136.
3[3]Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Laneet, 1998, 351 (9095): 9-13.
4[4]Inoue T, Sakuma M. Yaguchi I, et al. Early recanalization and plasma brain natriurctic peptide as an indicator of left ventricular function afteracute myocardial infrection. Am Heart J. 2002, 143 (5): 790-796.
5[5]Nagaya N, Nishikimi T, Goto Y, et al. Plasma brain natiuretic peptide isa hiochenical mnarker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J, 1998, 135 (1): 21-28.
6[6]Arakaw a N, Nakamura M, Aoki H, et al. Relationship hetween plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology, 1994, 85 (5): 334-340.
7[7]de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med, 2001, 345 (14): 1014-1021.
8[8]Kikuta K, Yasue H, Yoshimura M, et al. Increased plasna levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J, 1996, 132 (1 Pt 1): 101-107.
9[9]Suzuki M, Yamamoto K, Watanabe S, et al. Association between elevated brain natriuretic peptide levels and the development of left ventricular hy pertrophy in patients with hypertension. Am J Med, 2000, 108 (6): 627- 633.
